Clinical Trials List
Protocol Number20160275
Completed
2017-05-24 - 2022-09-30
Phase III
Terminated2
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- MING YAO Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- Chien-Yuan Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yao-Chung Liu Division of Hematology & Oncology
- Hao-Yuan Wang Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
450 participants
